About Amber Therapeutics
Amber Therapeutics develops an adaptive neuromodulation therapy for women with mixed urinary incontinence. Its fully implantable Picostim System targets the pudendal nerve to stimulate and sense physiological responses. The therapy is configurable to individual needs and adapts dynamically.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
London, United Kingdom
Year Founded
2022
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
amber-tx.com
Domain Registered Date
Dec 21, 2020
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-A announced
fundraisingfox.com
- Capital Raise
Raised $100,000,000 · Series-A
fundraisingfox.com
- Milestone
Company founded
London, United Kingdom
- Milestone
Website domain registered
amber-tx.com
Investors & Backers
8VC
F-Prime Capital
Future Fifty
Innovate UK
Intuitive Ventures
Lightstone Ventures
NEA
Oxford Science Enterprises
Funding History
Series-A
· Jul 24, 2026
Undisclosed fundraisingfox.com
Series-A
· Jun 10, 2024
$100,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026